老年患者围术期快速康复一体化智能管理辅助决策系统的构建及应用

注册号:

Registration number:

ChiCTR2500113831 

最近更新日期:

Date of Last Refreshed on:

2025-12-03 16:37:58 

注册时间:

Date of Registration:

2025-12-03 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

老年患者围术期快速康复一体化智能管理辅助决策系统的构建及应用

Public title:

Construction and Application of an Integrated Intelligent Management and Decision Support System for Enhanced Recovery of Elderly Patients in the Perioperative Period

注册题目简写:

English Acronym:

研究课题的正式科学名称:

老年患者围术期快速康复一体化智能管理辅助决策系统的构建及应用

Scientific title:

Construction and Application of an Integrated Intelligent Management and Decision Support System for Enhanced Recovery of Elderly Patients in the Perioperative Period

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

方浩 

研究负责人:

方浩 

Applicant:

Fang Hao 

Study leader:

Fang Hao 

申请注册联系人电话:

Applicant telephone:

+86 21 31118563

研究负责人电话:

Study leader's
telephone:

+86 21 64041990

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

drfanghao@163.com

研究负责人电子邮件:

Study leader's E-mail:

drfanghao@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

上海市闵行区春申路2560号

研究负责人通讯地址:

上海市闵行区春申路2560号

Applicant address:

2560 Chunshen Road, Minhang District, Shanghai

Study leader's address:

2560 Chunshen Road, Minhang District, Shanghai

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

上海市老年医学中心

Applicant's institution:

Shanghai Geriatric Medical Center

研究负责人所在单位:

复旦大学附属中山医院

Affiliation of the Leader:

Zhongshan Hospital, Fudan University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

B2025-044

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

上海市老年医学中心伦理委员会

Name of the ethic committee:

Ethics Committee of Shanghai Geriatric Medical Center

伦理委员会批准日期:

Date of approved by ethic committee:

2025-09-26 00:00:00

伦理委员会联系人:

陈宁华

Contact Name of the ethic committee:

Chen Ninghua

伦理委员会联系地址:

上海市闵行区春申路2560号

Contact Address of the ethic committee:

2560 Chunshen Road, Minhang District, Shanghai

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 21 31118563

伦理委员会联系人邮箱:

Contact email of the ethic committee:

chen.ninghua@zsgmc.sh.cn

研究实施负责(组长)单位:

上海市老年医学中心

Primary sponsor:

Shanghai Geriatric Medical Center

研究实施负责(组长)单位地址:

上海市闵行区春申路2560号

Primary sponsor's address:

2560 Chunshen Road, Minhang District, Shanghai

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

上海市

市(区县):

Country:

China

Province:

Shanghai

City:

单位(医院):

上海市老年医学中心

具体地址:

上海市闵行区春申路2560号

Institution
hospital:

Shanghai Geriatric Medical Center

Address:

2560 Chunshen Road, Minhang District, Shanghai

经费或物资来源:

上海市卫生健康委员会智慧医疗专项研究项目

Source(s) of funding:

Special Research Project on Smart Healthcare of Shanghai Municipal Health Commission

研究疾病:

老年手术患者围术期管理  

Target disease:

Perioperative Management of Elderly Surgical Patients

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

横断面 

Study design:

Cross-sectional 

研究目的:

基于国产算力资源池搭建老年患者围术期一体化快速康复智能辅助平台,集成大模型、先进学习算法,并在区域内的各层级医院开展前瞻性临床验证,最终进行推广和应用示范  

Objectives of Study:

Based on the domestic computing resource pool, an intelligent auxiliary platform for integrated enhanced recovery after surgery (ERAS) in elderly patients during the perioperative period will be built. This platform will integrate large models and advanced learning algorithms, followed by the launch of prospective clinical validation in hospitals at all levels within the region. Eventually, the platform will be promoted and applied as a demonstration.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

1.日间手术患者; 2.患有严重感染性疾病者; 3.恶性肿瘤晚期(预期生存期<3 个月)患者; 4.有严重精神障碍者; 5.近 3 个月内有重大手术史者; 6.严重肥胖(BMI>40kg/m^2)者; 7.处于妊娠或哺乳期的患者.

Exclusion criteria:

1.Day - surgery patients; 2.Patients with serious infectious diseases; 3.Patients with advanced malignant tumors (expected survival period < 3 months); 4.Patients with severe mental disorders; 5.Patients with a history of major surgery within the recent 3 months; 6.Patients with severe obesity (BMI > 40 kg/m^2); 7.Patients who are pregnant or lactating.

研究实施时间:

Study execute time:

From 2026-01-01 00:00:00 To 2028-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2026-01-01 00:00:00 To 2028-12-31 00:00:00

干预措施:

Interventions:

组别:

观察组

样本量:

3000

Group:

Observation group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

上海市 

市(区县):

 

Country:

China

Province:

Shanghai

City:

单位(医院):

上海市老年医学中心 

单位级别:

三级医院 

Institution
hospital:

Shanghai Geriatric Medical Center

Level of the institution:

Tertiary

测量指标:

Outcomes:

指标中文名:

术后 30 天内主要并发症(Clavien-Dindo 分级 ≥ IIIa 级)发生率

指标类型:

次要指标

Outcome:

Incidence of major complications (Clavien-Dindo classification >= Grade IIIa) within 30 days after surgery

Type:

Secondary indicator

测量时间点:

术后 30 天内

测量方法:

Measure time point of outcome:

within 30 days after surgery

Measure method:

指标中文名:

术后综合并发症指数

指标类型:

主要指标

Outcome:

Comprehensive Complication Index, CC

Type:

Primary indicator

测量时间点:

术后 30 天内

测量方法:

Measure time point of outcome:

within 30 days after surgery

Measure method:

指标中文名:

术后 30 天内全因死亡率

指标类型:

次要指标

Outcome:

all-cause mortality within 30 days after surgery

Type:

Secondary indicator

测量时间点:

术后 30 天

测量方法:

Measure time point of outcome:

within 30 days after surgery

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 60 years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

None

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

None

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

EDC

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

EDC

数据与安全监察委员会:

Data and Safety Monitoring Committee:

无/No

注册人:

Name of Registration:

 2025-12-03 16:37:15